EFDID: 146797EFD: Raw Data

Issuer: AYTU BIOSCIENCE, INC (0001385818) - D/A

Accession: 0001209191-15-071755 () (EDGAREDGAR Files) (Form DForm D)

Edgar Posted: Sep. 22, 2015
EFD Posted: Sep. 22, 2015
- < edgarSubmission >
  < schemaVersion > X0707 </ schemaVersion >
  < submissionType > D/A </ submissionType >
  < testOrLive > LIVE </ testOrLive >
- < primaryIssuer >
  < cik > 0001385818 </ cik >
  < entityName > AYTU BIOSCIENCE, INC </ entityName >
- < issuerAddress >
  < street1 > 373 Inverness Parkway </ street1 >
  < street2 > Suite 206 </ street2 >
  < city > Englewood </ city >
  < stateOrCountry > CO </ stateOrCountry >
  < stateOrCountryDescription > COLORADO </ stateOrCountryDescription >
  < zipCode > 80112 </ zipCode >
  </ issuerAddress >
  < issuerPhoneNumber > 720-437-6580 </ issuerPhoneNumber >
  < jurisdictionOfInc > COLORADO </ jurisdictionOfInc >
- < issuerPreviousNameList >
  < previousName > Rosewind Corporation </ previousName >
  </ issuerPreviousNameList >
- < edgarPreviousNameList >
  < previousName > AYTU BIOSCIENCE, INC. </ previousName >
  < previousName > Rosewind CORP </ previousName >
  </ edgarPreviousNameList >
  < entityType > Corporation </ entityType >
- < yearOfInc >
  < overFiveYears > true </ overFiveYears >
  </ yearOfInc >
  </ primaryIssuer >
- < relatedPersonsList >
- < relatedPersonInfo >
- < relatedPersonName >
  < firstName > Joshua </ firstName >
  < middleName > R. </ middleName >
  < lastName > Disbrow </ lastName >
  </ relatedPersonName >
- < relatedPersonAddress >
  < street1 > c/o AytuBioscience, Inc. </ street1 >
  < street2 > 373 Inverness Parkway, Suite 206 </ street2 >
  < city > Englewood </ city >
  < stateOrCountry > CO </ stateOrCountry >
  < stateOrCountryDescription > COLORADO </ stateOrCountryDescription >
  < zipCode > 80112 </ zipCode >
  </ relatedPersonAddress >
- < relatedPersonRelationshipList >
  < relationship > Executive Officer </ relationship >
  </ relatedPersonRelationshipList >
  </ relatedPersonInfo >
- < relatedPersonInfo >
- < relatedPersonName >
  < firstName > Jarrett </ firstName >
  < middleName > T. </ middleName >
  < lastName > Disbrow </ lastName >
  </ relatedPersonName >
- < relatedPersonAddress >
  < street1 > c/o Aytu Bioscience, Inc. </ street1 >
  < street2 > 373 Inverness Parkway, Suite 206 </ street2 >
  < city > Englewood </ city >
  < stateOrCountry > CO </ stateOrCountry >
  < stateOrCountryDescription > COLORADO </ stateOrCountryDescription >
  < zipCode > 80112 </ zipCode >
  </ relatedPersonAddress >
- < relatedPersonRelationshipList >
  < relationship > Executive Officer </ relationship >
  </ relatedPersonRelationshipList >
  < relationshipClarification />
  </ relatedPersonInfo >
- < relatedPersonInfo >
- < relatedPersonName >
  < firstName > Gregory </ firstName >
  < middleName > A. </ middleName >
  < lastName > Gould </ lastName >
  </ relatedPersonName >
- < relatedPersonAddress >
  < street1 > c/o Aytu Bioscience, Inc. </ street1 >
  < street2 > 373 Inverness Parkway, Suite 206 </ street2 >
  < city > Englewood </ city >
  < stateOrCountry > CO </ stateOrCountry >
  < stateOrCountryDescription > COLORADO </ stateOrCountryDescription >
  < zipCode > 80112 </ zipCode >
  </ relatedPersonAddress >
- < relatedPersonRelationshipList >
  < relationship > Executive Officer </ relationship >
  </ relatedPersonRelationshipList >
  < relationshipClarification />
  </ relatedPersonInfo >
- < relatedPersonInfo >
- < relatedPersonName >
  < firstName > Michael </ firstName >
  < lastName > Macaluso </ lastName >
  </ relatedPersonName >
- < relatedPersonAddress >
  < street1 > c/o Aytu Bioscience, Inc. </ street1 >
  < street2 > 373 Inverness Parkway, Suite 206 </ street2 >
  < city > Englewood </ city >
  < stateOrCountry > CO </ stateOrCountry >
  < stateOrCountryDescription > COLORADO </ stateOrCountryDescription >
  < zipCode > 80112 </ zipCode >
  </ relatedPersonAddress >
- < relatedPersonRelationshipList >
  < relationship > Director </ relationship >
  </ relatedPersonRelationshipList >
  < relationshipClarification />
  </ relatedPersonInfo >
  </ relatedPersonsList >
- < offeringData >
- < industryGroup >
  < industryGroupType > Pharmaceuticals </ industryGroupType >
  </ industryGroup >
- < issuerSize >
  < revenueRange > Decline to Disclose </ revenueRange >
  </ issuerSize >
- < federalExemptionsExclusions >
  < item > 06b </ item >
  </ federalExemptionsExclusions >
- < typeOfFiling >
- < newOrAmendment >
  < isAmendment > true </ isAmendment >
  < previousAccessionNumber > 0001209191-15-063890 </ previousAccessionNumber >
  </ newOrAmendment >
- < dateOfFirstSale >
  < value > 2015-08-31 </ value >
  </ dateOfFirstSale >
  </ typeOfFiling >
- < durationOfOffering >
  < moreThanOneYear > false </ moreThanOneYear >
  </ durationOfOffering >
- < typesOfSecuritiesOffered >
  < isDebtType > true </ isDebtType >
  </ typesOfSecuritiesOffered >
- < businessCombinationTransaction >
  < isBusinessCombinationTransaction > false </ isBusinessCombinationTransaction >
  < clarificationOfResponse />
  </ businessCombinationTransaction >
  < minimumInvestmentAccepted > 0 </ minimumInvestmentAccepted >
- < salesCompensationList >
- < recipient >
  < recipientName > Newbridge Securities Corporation </ recipientName >
  < recipientCRDNumber > 104065 </ recipientCRDNumber >
  < associatedBDName > None </ associatedBDName >
  < associatedBDCRDNumber > None </ associatedBDCRDNumber >
- < recipientAddress >
  < street1 > 1451 Cypress Creek Road, Suite 204 </ street1 >
  < city > Ft. Lauderdale </ city >
  < stateOrCountry > FL </ stateOrCountry >
  < stateOrCountryDescription > FLORIDA </ stateOrCountryDescription >
  < zipCode > 33309 </ zipCode >
  </ recipientAddress >
  < statesOfSolicitationList />
  </ recipient >
  </ salesCompensationList >
- < offeringSalesAmounts >
  < totalOfferingAmount > 6000000 </ totalOfferingAmount >
  < totalAmountSold > 5175000 </ totalAmountSold >
  < totalRemaining > 825000 </ totalRemaining >
  < clarificationOfResponse />
  </ offeringSalesAmounts >
- < investors >
  < hasNonAccreditedInvestors > false </ hasNonAccreditedInvestors >
  < totalNumberAlreadyInvested > 96 </ totalNumberAlreadyInvested >
  </ investors >
- < salesCommissionsFindersFees >
- < salesCommissions >
  < dollarAmount > 244000 </ dollarAmount >
  </ salesCommissions >
- < findersFees >
  < dollarAmount > 0 </ dollarAmount >
  </ findersFees >
  < clarificationOfResponse />
  </ salesCommissionsFindersFees >
- < useOfProceeds >
- < grossProceedsUsed >
  < dollarAmount > 0 </ dollarAmount >
  </ grossProceedsUsed >
  < clarificationOfResponse > Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering. </ clarificationOfResponse >
  </ useOfProceeds >
- < signatureBlock >
  < authorizedRepresentative > false </ authorizedRepresentative >
- < signature >
  < issuerName > AYTU BIOSCIENCE, INC </ issuerName >
  < signatureName > /s/ Gregory A. Gould </ signatureName >
  < nameOfSigner > Gregory A. Gould </ nameOfSigner >
  < signatureTitle > Chief Financial Officer </ signatureTitle >
  < signatureDate > 2015-09-21 </ signatureDate >
  </ signature >
  </ signatureBlock >
  </ offeringData >
  </ edgarSubmission >
Edgar Posted: Sep. 22, 2015
EFD Posted: Sep. 22, 2015